• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板生成素与钢因子和/或白细胞介素-3协同作用,支持人类原始造血细胞的增殖。

Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3.

作者信息

Kobayashi M, Laver J H, Kato T, Miyazaki H, Ogawa M

机构信息

Department of Pediatrics and Medicine, Medical University of South Carolina, Charleston, USA.

出版信息

Blood. 1996 Jul 15;88(2):429-36.

PMID:8695789
Abstract

We have studied the effects of recombinant human thrombopoietin (TPO; mpl ligand) on the proliferation of human primitive hematopoietic progenitors in vitro. CD34+ cells were enriched for cell-cycle-dormant primitive progenitors by separation on the basis of expression of c-kit and CD38. In the presence of varying combinations of TPO, Steel factor (SF), and interleukin-3 (IL-3), CD34+/c-kit(low)/CD38neg/low cells produced fewer colonies than CD34+/c-kit(low)/CD38high cells. However, when cultured in suspension for 7 days and replated in methylcellulose culture for measurement of colony-forming cells, the former population generated more colony-forming cells than the latter. In suspension culture of CD34+/c-kit(low)/CD38neg/low cells, TPO acted synergistically with SF and/or IL-3 in support of the production of colony-forming cells for granulocyte/macrophage colonies, erythroid colonies, and mixed colonies. Culture studies of individual CD34+/c-kit(low)/CD38neg/low cells provided the evidence for the direct nature of the effects of TPO. When combined with SF, TPO showed stronger stimulation of production of progenitors in suspension culture than other early-acting factors, such as IL-6, IL-11, and granulocyte colony-stimulating factor (G-CSF). TPO may be an important cytokine for in vitro manipulation of human hematopoietic stem cells.

摘要

我们研究了重组人血小板生成素(TPO;mpl配体)对人原始造血祖细胞体外增殖的影响。通过基于c-kit和CD38表达进行分离,富集出处于细胞周期静止状态的原始祖细胞的CD34+细胞。在血小板生成素(TPO)、干细胞因子(SF)和白细胞介素-3(IL-3)的不同组合存在的情况下,CD34+/c-kit(低)/CD38阴性/低表达细胞形成的集落比CD34+/c-kit(低)/CD38高表达细胞少。然而,当在悬浮培养中培养7天,然后重新接种到甲基纤维素培养基中以测量集落形成细胞时,前一组产生的集落形成细胞比后一组多。在CD34+/c-kit(低)/CD38阴性/低表达细胞的悬浮培养中,TPO与SF和/或IL-3协同作用,支持粒细胞/巨噬细胞集落、红系集落和混合集落的集落形成细胞的产生。对单个CD34+/c-kit(低)/CD38阴性/低表达细胞的培养研究为TPO作用的直接性质提供了证据。当与SF联合使用时,TPO在悬浮培养中对祖细胞产生的刺激作用比其他早期作用因子,如IL-6、IL-11和粒细胞集落刺激因子(G-CSF)更强。TPO可能是体外操纵人造血干细胞的一种重要细胞因子。

相似文献

1
Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3.血小板生成素与钢因子和/或白细胞介素-3协同作用,支持人类原始造血细胞的增殖。
Blood. 1996 Jul 15;88(2):429-36.
2
Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice.血小板生成素,即Mpl受体的配体,可与干细胞因子及其他早期起作用的细胞因子协同作用,以支持小鼠原始造血祖细胞的增殖。
Blood. 1996 Jun 1;87(11):4544-51.
3
Thrombopoietin, steel factor and the ligand for flt3/flk2 interact to stimulate the proliferation of human hematopoietic progenitors in culture.
Int J Hematol. 1997 Dec;66(4):423-34. doi: 10.1016/s0925-5710(97)00066-2.
4
Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.白细胞介素-11刺激人造血CD34+和CD34+CD33-DR-细胞的增殖,并与干细胞因子、白细胞介素-3和粒细胞-巨噬细胞集落刺激因子协同作用。
Exp Hematol. 1993 Dec;21(13):1668-72.
5
Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.在含有早期效应细胞因子的限定无血清培养基(QBSF-60)中对CD34+脐带血细胞进行体外扩增。
J Hematother Stem Cell Res. 1999 Dec;8(6):609-18. doi: 10.1089/152581699319777.
6
Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.重组人血小板生成素单独及与促红细胞生成素和早期作用细胞因子联合应用对在无血清培养基中培养的人动员纯化CD34+祖细胞的影响。
Stem Cells. 1997;15(1):18-32. doi: 10.1002/stem.150018.
7
Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin.早期作用细胞因子在单细胞水平直接促进具有多系分化潜能的人原始CD34+CD38-骨髓细胞存活并抑制其凋亡的能力:血小板生成素的关键作用
Blood. 1997 Sep 15;90(6):2282-92.
8
Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.干细胞因子(c-kit配体)增强人CD34+和CD34+CD33-DR-细胞依赖白细胞介素-9的增殖。
Exp Hematol. 1994 Aug;22(9):919-23.
9
Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3.血小板生成素而非促红细胞生成素,与早期作用的细胞因子协同作用,直接刺激原始小鼠骨髓祖细胞的多谱系生长:与c-kit和FLT3配体的不同相互作用。
Blood. 1996 Dec 15;88(12):4481-92.
10
Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro.血小板生成素(c-mpl配体)与促红细胞生成素、干细胞因子和白细胞介素-11协同作用,以增强小鼠巨核细胞集落生长,并在体外增加巨核细胞的倍性。
Blood. 1995 Apr 1;85(7):1719-26.

引用本文的文献

1
Development and characterization of a preclinical total marrow irradiation conditioning-based bone marrow transplant model for sickle cell disease.镰状细胞病基于临床前全身骨髓照射预处理的骨髓移植模型的建立与特性分析
Front Oncol. 2022 Sep 6;12:969429. doi: 10.3389/fonc.2022.969429. eCollection 2022.
2
A molecular roadmap of the AGM region reveals BMPER as a novel regulator of HSC maturation.主动脉-性腺-中肾区的分子图谱揭示BMPER是造血干细胞成熟的新型调节因子。
J Exp Med. 2017 Dec 4;214(12):3731-3751. doi: 10.1084/jem.20162012. Epub 2017 Nov 1.
3
Carica papaya induces in vitro thrombopoietic cytokines secretion by mesenchymal stem cells and haematopoietic cells.
番木瓜诱导间充质干细胞和造血细胞在体外分泌血小板生成细胞因子。
BMC Complement Altern Med. 2015 Jul 8;15:215. doi: 10.1186/s12906-015-0749-6.
4
Designer cytokine hyper interleukin 11 (H11) is a megakaryopoietic factor.设计细胞因子超白细胞介素 11 (H11) 是一种巨核细胞生成因子。
Int J Med Sci. 2013 Jul 9;10(9):1157-65. doi: 10.7150/ijms.5638. Print 2013.
5
Donor hematopoietic stem cells confer long-term marrow reconstitution by self-renewal divisions exceeding to that of host cells.供者造血干细胞通过自我更新分裂超过宿主细胞,从而长期重建骨髓。
PLoS One. 2012;7(12):e50693. doi: 10.1371/journal.pone.0050693. Epub 2012 Dec 5.
6
Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis.艾曲泊帕,一种血小板生成素受体激动剂,可增强人脐带血造血干细胞/原始祖细胞的扩增,并促进多谱系造血。
Stem Cell Res. 2012 Sep;9(2):77-86. doi: 10.1016/j.scr.2012.05.001. Epub 2012 May 14.
7
In vitro megakaryocyte production and platelet biogenesis: state of the art.体外巨核细胞生成和血小板生成:最新进展。
Transfus Med Rev. 2010 Jan;24(1):33-43. doi: 10.1016/j.tmrv.2009.09.003.
8
Development, migration, and survival of mast cells.肥大细胞的发育、迁移及存活
Immunol Res. 2006;34(2):97-115. doi: 10.1385/IR:34:2:97.
9
In vitro culture during retroviral transduction improves thymic repopulation and output after total body irradiation and autologous peripheral blood progenitor cell transplantation in rhesus macaques.在恒河猴中,逆转录病毒转导过程中的体外培养可改善全身照射和自体外周血祖细胞移植后的胸腺重建及输出。
Stem Cells. 2006 Jun;24(6):1539-48. doi: 10.1634/stemcells.2005-0455. Epub 2006 Feb 23.
10
The molecular mechanisms that control thrombopoiesis.控制血小板生成的分子机制。
J Clin Invest. 2005 Dec;115(12):3339-47. doi: 10.1172/JCI26674.